Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bevacizumab (avastin) (1 trial)
magnesium (1 trial)
nebivolol (bystolic) (1 trial)
potassium chloride (klor-con) (1 trial)
risuteganib (2 trials)
sodium acetate (1 trial)
sodium chloride (1 trial)
timolol (blocadren) (1 trial)
zinc dichloride (1 trial)
olx10212 (1 trial)
Diabetic Retinopathy (Phase 2)
Edema (Phase 2)
Macular Edema (Phase 2)
Retinal Diseases (Phase 2)
Trials (4 total)
Trial APIs (10 total)